pLADD / Novartis - LARVOL DELTA

Study of Personalized Immunotherapy in Adults With Metastatic Colorectal Cancer (clinicaltrials.gov) - P1; N=28; Terminated; Sponsor: Aduro Biotech, Inc.; Trial completion date: Dec 2020 ➔ Sep 2020; Active, not recruiting ➔ Terminated; Trial primary completion date: Dec 2020 ➔ Oct 2019; Study terminated due to business realignment

Clinical • Trial completion date • Trial primary completion date • Trial termination • Colorectal Cancer • Gastrointestinal Cancer • Oncology • Solid Tumor